Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @celularity
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @celularity
-
Prikvačeni tweet
Today we announced a lease agreement for a new state-of-the-art
#celltherapy manufacturing facility and integrated campus in#FlorhamPark. Learn more about our plans http://bit.ly/2X2Oupx pic.twitter.com/XBNJDjV3Si
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Celularity proslijedio/la je Tweet
With Ambassador Hwang, Hank Greenberg and
@celularity Chief Science Officer Xiaokui Zhangpic.twitter.com/gKYnSolz82
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Development for Coronavirus Infection https://bit.ly/313yqah pic.twitter.com/u3iyvDEP9B
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The FDA clearance of our IND application for CYNK-001 allows us to initiate the first U.S. clinical investigation of an allogeneic NK Cell therapy administered intravenously or intratumorally in patients with
#Glioblastoma Multiforme. Learn more: https://prn.to/30Owy51 pic.twitter.com/Tmhewb7IMi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Celularity proslijedio/la je Tweet
John Sculley (
@johnsculley), former@Apple CEO turned high-tech investor, places@celularity founder/CEO Robert Hariri (@HaririRobert) as a "visionary" in same league as Steve Jobs! Here's my#video interview of Dr. Hariri during 2019@CNSSummithttps://www.youtube.com/watch?v=PlW1aEDDqjo …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today we announced FDA clearance of our IND application for CYNK-001, an allogeneic, off-the-Shelf, cryopreserved NK Cell Therapy as treatment for
#Glioblastoma Multiforme: https://bwnews.pr/2vdqhnS pic.twitter.com/L4pMBH75mo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Celularity proslijedio/la je Tweet
Placental stem cell derived NK cells are effective against multiple myeloma - Myeloma Research News
@maalvima14@celularity Preliminary results from Phase 1 trial look promising#StemCells#StemCellsTherapy#CancerTreatment#CancerAwarenesshttps://liveforever.club/article/aualsai983?title=placental-stem-cell-derived-nk-cells-are-effective-against-multiple-myeloma …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Celularity proslijedio/la je Tweet
#PNK-007 Treatment After#StemCellTransplant Leads to Good Response Rates in Multiple#Myeloma Patients,@celularity early trial data showshttp://ow.ly/WujM50xQEaQHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
ICYMI, we introduced new pre-clinical data from our CAR T and NK cell therapy programs at
#ASH2019. Learn more: http://bit.ly/2PrvvTj pic.twitter.com/vEqxe2TdW6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to everyone who connected with us at
#ASH19. We enjoyed discussing data from our genetically-modified NK- and T cell-based programs. Celularity is committed to advancing innovation in#oncology!pic.twitter.com/1aju2VFEgx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today we announced new pre-clinical and clinical data that further demonstrates the versatility of our allogeneic, off the shelf, placental-derived cell therapy platform. Learn more about the new clinical and pre-clinical data presented at
#ASH2019: http://bit.ly/2JWpLPB pic.twitter.com/ccxuk67dte
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Attending
#ASH19? Don’t forget to stop by our poster and learn more about the exciting updates from our oncology programs.pic.twitter.com/pU9vxoluJa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're proud to share that recently, our CEO,
@HaririRobert, was awarded a 2019 Genius Innovators Award by the@LibertySciCtr . Help us congratulate him and the other award recipients#BonnieBassler,#DavidRosenberg, and@SebastianThrun on this incredible honor!pic.twitter.com/ijnfAzOe7E
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Celularity proslijedio/la je Tweet
.
@HaririRobert is one of the honorees at#GeniusOfNJ on Dec. 2. The Chairman, Founder & CEO of@celularity, Hariri is pioneering the use of stem cells to cure disease and slow aging. Learn more: https://bit.ly/37BHoyx pic.twitter.com/hmKVVg3xf8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At Celularity, we're working to develop novel invesgiational therapies for those with
#MultipleMyeloma, acute myeloid#leukemia, and#glioblastoma. Learn more about us and our approach: http://bit.ly/2W580Vy pic.twitter.com/lRXm5d2Up9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn more about the preclinical data we are presenting at
#SNO2019 supporting our proprietary PNK allogeneic cell therapy platform as an investigational treatment in development for#glioblastoma. http://bit.ly/2JWpLPB pic.twitter.com/OQ99lgw5S4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We look forward to participating in
#SNO2019 in Phoenix, Arizona. Visit our poster presentation on Nov. 22nd to learn more about the potential of our proprietary PNK allogeneic cell therapy platform as an Investigational treatment in development for#glioblastoma.pic.twitter.com/u5MSek6JBd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We had a productive time at
#SITC2019! Thanks to all who came to our posters and met with us to discuss innovative technologies and novel investigational treatments. It's an exciting time for cell-based#immunotherapies. We look forward to next year's meeting.pic.twitter.com/VLyPrPV74s
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today we're at
@BioNJ_Org's Seventh Annual C-Suite Summit to discuss ways to drive medical innovation and bring better treatments to patients with other industry leaders. Learn more about the event: http://bit.ly/2WVEcZn pic.twitter.com/GqSiQZPVAV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are excited to share our innovative research at
#SITC2019. Be sure to check out our poster presentations on Nov. 9, 2019, highlighting new research and preclinical data from our oncology programs in#MultipleMyeloma and#glioblastoma.pic.twitter.com/2nG0C9RBQQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.